141 related articles for article (PubMed ID: 37963811)
21. Crystal structures of human ENPP1 in apo and bound forms.
Dennis ML; Newman J; Dolezal O; Hattarki M; Surjadi RN; Nuttall SD; Pham T; Nebl T; Camerino M; Khoo PS; Monahan BJ; Peat TS
Acta Crystallogr D Struct Biol; 2020 Sep; 76(Pt 9):889-898. PubMed ID: 32876064
[TBL] [Abstract][Full Text] [Related]
22. Maintenance of cyclic GMP-AMP homeostasis by ENPP1 is involved in pseudorabies virus infection.
Wang J; Lu SF; Wan B; Ming SL; Li GL; Su BQ; Liu JY; Wei YS; Yang GY; Chu BB
Mol Immunol; 2018 Mar; 95():56-63. PubMed ID: 29407577
[TBL] [Abstract][Full Text] [Related]
23. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway.
Wang S; Böhnert V; Joseph AJ; Sudaryo V; Swinderman J; Yu FB; Lyu X; Skariah G; Subramanyam V; Gilbert LA; Goodarzi H; Lingyin L
bioRxiv; 2023 Jun; ():. PubMed ID: 37333273
[TBL] [Abstract][Full Text] [Related]
24. Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway.
Ding C; Song Z; Shen A; Chen T; Zhang A
Acta Pharm Sin B; 2020 Dec; 10(12):2272-2298. PubMed ID: 33354501
[TBL] [Abstract][Full Text] [Related]
25. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
[TBL] [Abstract][Full Text] [Related]
26. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.
Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT
Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751
[TBL] [Abstract][Full Text] [Related]
27. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression.
Ma XY; Chen MM; Meng LH
Acta Pharmacol Sin; 2024 May; 45(5):890-899. PubMed ID: 38177693
[TBL] [Abstract][Full Text] [Related]
28. Structure-based virtual screening and
Rohilla A; Singh AK; Koleske B; Srikrishna G; Bishai WR
Microbiol Spectr; 2024 Jan; 12(1):e0201223. PubMed ID: 38095464
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.
Czapla J; Drzyzga A; Matuszczak S; Cichoń T; Rusin M; Jarosz-Biej M; Pilny E; Smolarczyk R
Front Oncol; 2023; 13():1249524. PubMed ID: 37655095
[TBL] [Abstract][Full Text] [Related]
30. Encapsulation of STING Agonist cGAMP with Folic Acid-Conjugated Liposomes Significantly Enhances Antitumor Pharmacodynamic Effect.
Lu X; Cheng H; Xu Q; Tan X
Cancer Biother Radiopharm; 2023 Oct; 38(8):543-557. PubMed ID: 33719535
[No Abstract] [Full Text] [Related]
31. STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer.
Da Y; Liu Y; Hu Y; Liu W; Ma J; Lu N; Zhang C; Zhang C
Oncoimmunology; 2022; 11(1):2054105. PubMed ID: 35371622
[TBL] [Abstract][Full Text] [Related]
32. Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer.
Kawaguchi M; Han X; Hisada T; Nishikawa S; Kano K; Ieda N; Aoki J; Toyama T; Nakagawa H
J Med Chem; 2019 Oct; 62(20):9254-9269. PubMed ID: 31536342
[TBL] [Abstract][Full Text] [Related]
33. Discovery of VH domains that allosterically inhibit ENPP1.
Solomon PE; Bracken CJ; Carozza JA; Wang H; Young EP; Wellner A; Liu CC; Sweet-Cordero EA; Li L; Wells JA
Nat Chem Biol; 2024 Jan; 20(1):30-41. PubMed ID: 37400538
[TBL] [Abstract][Full Text] [Related]
34. Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer.
Liu C; Wang X; Qin W; Tu J; Li C; Zhao W; Ma L; Liu B; Qiu H; Yuan X
Cancer Commun (Lond); 2023 Apr; 43(4):435-454. PubMed ID: 36855844
[TBL] [Abstract][Full Text] [Related]
35. Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models.
Jekle A; Thatikonda SK; Jaisinghani R; Ren S; Kinkade A; Stevens SK; Stoycheva A; Rajwanshi VK; Williams C; Deval J; Mukherjee S; Zhang Q; Chanda S; Smith DB; Blatt LM; Symons JA; Gonzalvez F; Beigelman L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003463
[TBL] [Abstract][Full Text] [Related]
36. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): Synthesis, transmission, and degradation.
Su M; Zheng J; Gan L; Zhao Y; Fu Y; Chen Q
Biochem Pharmacol; 2022 Apr; 198():114934. PubMed ID: 35104477
[TBL] [Abstract][Full Text] [Related]
37. Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.
Lai J; Fu Y; Tian S; Huang S; Luo X; Lin L; Zhang X; Wang H; Lin Z; Zhao H; Lin S; Zhao J; Xu S; Li D; Cai S; Dong L; Qian J; Liang J; Li Q; Zhang Y; Fan J; Balderas R; Chen Q
Mol Ther; 2021 May; 29(5):1758-1771. PubMed ID: 33571681
[TBL] [Abstract][Full Text] [Related]
38. Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.
Li J; Duran MA; Dhanota N; Chatila WK; Bettigole SE; Kwon J; Sriram RK; Humphries MP; Salto-Tellez M; James JA; Hanna MG; Melms JC; Vallabhaneni S; Litchfield K; Usaite I; Biswas D; Bareja R; Li HW; Martin ML; Dorsaint P; Cavallo JA; Li P; Pauli C; Gottesdiener L; DiPardo BJ; Hollmann TJ; Merghoub T; Wen HY; Reis-Filho JS; Riaz N; Su SM; Kalbasi A; Vasan N; Powell SN; Wolchok JD; Elemento O; Swanton C; Shoushtari AN; Parkes EE; Izar B; Bakhoum SF
Cancer Discov; 2021 May; 11(5):1212-1227. PubMed ID: 33372007
[TBL] [Abstract][Full Text] [Related]
39. Arabinose- and xylose-modified analogs of 2',3'-cGAMP act as STING agonists.
Xie W; Lama L; Yang X; Kuryavyi V; Bhattacharya S; Nudelman I; Yang G; Ouerfelli O; Glickman JF; Jones RA; Tuschl T; Patel DJ
Cell Chem Biol; 2023 Nov; 30(11):1366-1376.e7. PubMed ID: 37536341
[TBL] [Abstract][Full Text] [Related]
40. The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma.
Li K; Ye Y; Liu L; Sha Q; Wang X; Jiao T; Zhang L; Wang J
Biomater Sci; 2021 Feb; 9(3):765-773. PubMed ID: 33201161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
